Tri Locum Partners LP’s Madrigal Pharmaceuticals Inc Position
Does Tri Locum Partners LP own Madrigal Pharmaceuticals Inc (MDGL)? Yes — 103.3K shares worth $54M (+7.59% of its 13F portfolio) as of Q1 2026, up from 86.0K shares the prior filed quarter.
Position Value
$54M
Q1 2026
Shares
103.3K
% of Portfolio
+7.59%
Quarters Held
14
currently held
Position History MDGL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 103.3K | $54M | +7.59% |
| Q4 2025 | 86.0K | $50M | +6.50% |
| Q3 2025 | 67.7K | $31M | +7.14% |
| Q2 2025 | 97.8K | $30M | +8.98% |
| Q1 2025 | 37.9K | $13M | +6.44% |
| Q4 2024 | 47.5K | $15M | +3.03% |
| Q3 2024 | 43.3K | $9M | +2.20% |
| Q2 2024 | 65.4K | $18M | +4.63% |
| Q1 2024 | 53.4K | $14M | +4.94% |
| Q4 2023 | 25.5K | $6M | +2.70% |
| Q3 2023 | 33.8K | $5M | +1.58% |
| Q2 2023 | 26.0K | $6M | +2.23% |
| Q1 2023 | 13.8K | $3M | +1.02% |
| Q4 2022 | 26.4K | $8M | +3.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of MDGL.